Extracorporeal Photopheresis—An Overview

Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of cutaneous T-cell lymphoma (CTCL) in 1988. After the first positive experiences with CTCL, additional indications have been su...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Ara, Jantschitsch, Christian, Knobler, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119964/
https://www.ncbi.nlm.nih.gov/pubmed/30211164
http://dx.doi.org/10.3389/fmed.2018.00236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119964/
https://www.ncbi.nlm.nih.gov/pubmed/30211164
http://dx.doi.org/10.3389/fmed.2018.00236

Ejemplares similares